EATON VANCE OHIO MUNICIPAL INCOME TRUST

(EVO)
SummaryChartsNewsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Evotec, Bristol Myers Expand Neurogenerative Partnership to Include New Targeted Protein Degradation Approach

01/11/2022 | 02:19pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BRISTOL-MYERS SQUIBB COMPANY 0.30% 76.19 Delayed Quote.22.20%
EATON VANCE OHIO MUNICIPAL INCOME TRUST 0.08% 12.62 End-of-day quote.3.95%
EVOTEC SE 2.18% 25.32 Delayed Quote.-40.42%
All news about EATON VANCE OHIO MUNICIPAL INCOME TRUST
05/19Evotec Working With Almirall to Develop New Therapies for Skin Diseases
MT
05/10Evotec Expands Partnership With Bristol Myers Squibb
MT
04/12SECTOR UPDATE : Health Care Stocks Ending Near Intra-Day Lows
MT
04/12SECTOR UPDATE : Health Care
MT
04/12Evotec FY2021 Earnings, Revenue Rise; Provides FY2022 Guidance
MT
03/21Evotec Gets $3.3 Million Milestone Payment as Potential Diabetic Neuropathic Pain Treat..
MT
02/15Evotec Invests in Biotechnology Company IMIDomics; Shares Gain
MT
02/04SECTOR UPDATE : Health Care Stocks Mixed in Late Trade
MT
02/04SECTOR UPDATE : Health Care Stocks Still Struggling This Afternoon
MT
02/04SECTOR UPDATE : Health Care
MT
More news
Analyst Recommendations on EATON VANCE OHIO MUNICIPAL INCOME TRUST
More recommendations
Chart EATON VANCE OHIO MUNICIPAL INCOME TRUST
Duration : Period :
Eaton Vance Ohio Municipal Income Trust Technical Analysis Chart | EVO | US27826G1094 | MarketScreener